Adequate selection of patients for thyroid biopsy: evaluation of a shared decision making conversation aid
甲状腺活检患者的充分选择:共享决策对话辅助工具的评估
基本信息
- 批准号:10662303
- 负责人:
- 金额:$ 21.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultAffectBankruptcyBiopsyCaringClinicClinicalClinical TrialsClinical Trials DesignCollaborationsCommunicationComplexControl GroupsCounselingDecision MakingDiagnosisDiagnosticEconomic BurdenElectronicsEmotionalEnrollmentEpidemicEvaluationFeedbackFloridaFutureGoalsGuidelinesIncidenceIncidental DiscoveriesIndolentInternationalInterviewInvestigationK-Series Research Career ProgramsLeftLifeMalignant NeoplasmsMalignant neoplasm of thyroidMedicalMentorsMulticenter TrialsNational Cancer InstituteNoduleOncologyParticipantPatient CarePatient PreferencesPatient SelectionPatient-Centered CarePatientsPersonsPractice GuidelinesPrincipal InvestigatorProcessPrognosisQualitative ResearchQuality of lifeRandomizedRecommendationResearchResearch MethodologyResearch PersonnelRiskScientistStructureSystemThyroid GlandThyroid NoduleUnited StatesUniversitiesUpdateVisitWomanWorkanxiouscancer carecancer diagnosiscancer riskcare costscareer developmentclinical practicedesignefficacy evaluationefficacy trialexperiencefield studygroup interventionimaging detectionimplementation barriersimplementation scienceimprovedindividual patientinterestmenmultidisciplinarynovelovertreatmentpatient engagementpatient orientedpatient-level barriersprototyperandomized trialshared decision makingultrasound
项目摘要
Summary
This Mentored Clinical Scientist Research Career Development Award (K08) by the National Cancer Institute is
designed to provide the principal investigator Dr. Naykky Singh Ospina with the support to become an
independent investigator in the field of patient centered thyroid cancer care. There is an epidemic of thyroid
cancer diagnosis that directly harms patients and overwhelms the medical system. Indiscriminate biopsy of
thyroid nodules without engagement of patients in the decision making process leads to over diagnosis of more
than 50% of the 50,000 patients that are diagnosed with thyroid cancer annually in the United States.
Conversation aids can support shared decision making in clinical practice and allow patients and clinicians to
collaborate and find the medical decision that fits the needs of individual patients. As such, a conversation aid
to support the decision making regarding the need for thyroid biopsy and thyroid cancer diagnosis, is a novel
proposal that can lead to a more careful approach to thyroid cancer diagnosis. The proposed research seeks
to: AIM1. Update a conversation aid prototype that was developed to support shared decision making in the
diagnosis of thyroid cancer and AIM2. Conduct a pilot clinical trial to evaluate the feasibility of conducting a
larger study evaluating the efficacy of this conversation aid in supporting shared decision making, decreasing
the number of unnecessary thyroid biopsies and leading to improved patient centered thyroid cancer diagnosis.
To achieve AIM1, we will conduct semi-structured interviews of patients and clinicians who have used the
conversation aid in the decision-making process and evaluate recordings of these clinical visits, to obtain
through qualitative research methods an in-depth understanding of their experience using the conversation aid
and feedback to update the conversation aid prototype. In AIM2, this updated conversation aid will be used in a
pilot randomized trial, where patients presenting for evaluation of thyroid nodules will be randomized to receive
counseling about thyroid biopsy and thyroid cancer diagnosis, to receive care using conversation aid
(intervention group) or not using the conversation aid (control group). The results of this study will inform the
feasibility and design of a larger study, to evaluate the efficacy of supporting shared decision making on the
rate of unnecessary thyroid biopsies and thyroid cancer diagnosis. The long-term goal of this research is to
support shared decision-making and patient centered thyroid cancer diagnosis. Dr. Singh Ospina, will receive
formal course work in qualitative research, communication and implementation science, and clinical trials
design. In addition, she has an exceptional and committed multidisciplinary mentoring team that includes
internationally recognized experts in the fields of interest. This team will support her career development and
mentored research experience. The long term goals are for Dr. Singh Ospina to become an independent
investigator in the field of patient centered thyroid cancer care and evaluating a conversation aid that can help
decrease the over diagnosis of thyroid cancer, and it’s harms.
总结
这个指导临床科学家研究职业发展奖(K08)由国家癌症研究所是
旨在为首席研究员Naykky Singh Ospina博士提供支持,
在以患者为中心的甲状腺癌护理领域的独立研究者。有一种流行病甲状腺
癌症诊断直接伤害患者并扰乱医疗系统。不分青红皂白的活检
甲状腺结节在没有患者参与决策过程的情况下,会导致更多的过度诊断。
在美国,每年被诊断患有甲状腺癌的50,000名患者中有超过50%。
会话辅助工具可以支持临床实践中的共享决策,并允许患者和临床医生
协作并找到适合个体患者需求的医疗决策。因此,一种谈话辅助设备,
支持甲状腺活检和甲状腺癌诊断的决策,是一种新的
这一建议可以导致更仔细的甲状腺癌诊断方法。拟议的研究旨在
目标:AIM1。更新一个对话辅助原型,该原型是为支持
甲状腺癌和AIM的诊断2.开展试点临床试验,以评估开展
一项更大规模的研究评估了这种对话辅助工具在支持共同决策方面的功效,
不必要的甲状腺活检的数量,并导致改善以患者为中心的甲状腺癌诊断。
为了实现AIM 1,我们将对使用过
在决策过程中的谈话援助,并评估这些临床访问的记录,以获得
通过定性研究方法深入了解他们使用会话辅助工具的经历
和反馈来更新会话辅助原型。在AIM 2中,此更新的会话辅助将用于
初步随机试验,其中接受甲状腺结节评价的患者将随机接受
关于甲状腺活组织检查和甲状腺癌诊断的咨询,使用谈话辅助工具接受护理
(干预组)或不使用会话辅助工具(对照组)。这项研究的结果将告知
一项更大规模研究的可行性和设计,以评估支持共同决策对
不必要的甲状腺活检和甲状腺癌诊断率。这项研究的长期目标是
支持共同决策和以患者为中心的甲状腺癌诊断。辛格·奥斯皮纳博士将接受
在定性研究,沟通和实施科学,和临床试验的正式课程工作
设计此外,她还拥有一支出色而敬业的多学科指导团队,其中包括
国际公认的专家在感兴趣的领域。该团队将支持她的职业发展,
指导研究经验。长期目标是让辛格·奥斯皮纳博士成为一名独立的
以患者为中心的甲状腺癌护理领域的调查员,并评估可以帮助
减少甲状腺癌的过度诊断及其危害。
项目成果
期刊论文数量(36)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
De-implementing low-value care in endocrinology.
- DOI:10.1007/s12020-021-02732-y
- 发表时间:2021-08
- 期刊:
- 影响因子:3.7
- 作者:Ospina NS;Salloum RG;Maraka S;Brito JP
- 通讯作者:Brito JP
Does the duration of ambulatory consultations affect the quality of healthcare? A systematic review.
- DOI:10.1136/bmjoq-2023-002311
- 发表时间:2023-10
- 期刊:
- 影响因子:1.4
- 作者:
- 通讯作者:
Development and pilot testing of a conversation aid to support the evaluation of patients with thyroid nodules.
- DOI:10.1111/cen.14599
- 发表时间:2022-04
- 期刊:
- 影响因子:3.2
- 作者:Singh Ospina NM;Bagautdinova D;Hargraves I;Barb D;Subbarayan S;Srihari A;Wang S;Maraka S;Bylund CL;Treise D;Montori V;Brito JP
- 通讯作者:Brito JP
Clinician Agreement on the Classification of Thyroid Nodules Ultrasound Features: A Survey of 2 Endocrine Societies.
临床医生对甲状腺结节超声特征分类的一致意见:两个内分泌学会的调查。
- DOI:10.1210/clinem/dgac279
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Burgos,Nydia;Zhao,Jing;Brito,JuanP;Hoang,JennyK;Pitoia,Fabian;Maraka,Spyridoula;Castro,MRegina;Lee,Ji-Hyun;SinghOspina,Naykky
- 通讯作者:SinghOspina,Naykky
Ultrasound Image Classification of Thyroid Nodules Using Machine Learning Techniques.
- DOI:10.3390/medicina57060527
- 发表时间:2021-05-24
- 期刊:
- 影响因子:0
- 作者:Vadhiraj VV;Simpkin A;O'Connell J;Singh Ospina N;Maraka S;O'Keeffe DT
- 通讯作者:O'Keeffe DT
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Naykky Singh Ospina其他文献
Naykky Singh Ospina的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Naykky Singh Ospina', 18)}}的其他基金
Adequate selection of patients for thyroid biopsy: evaluation of a shared decision making conversation aid
甲状腺活检患者的充分选择:共享决策对话辅助工具的评估
- 批准号:
10158465 - 财政年份:2020
- 资助金额:
$ 21.96万 - 项目类别:
Adequate selection of patients for thyroid biopsy: evaluation of a shared decision making conversation aid
甲状腺活检患者的充分选择:共享决策对话辅助工具的评估
- 批准号:
10437629 - 财政年份:2020
- 资助金额:
$ 21.96万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 21.96万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 21.96万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 21.96万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 21.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 21.96万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 21.96万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 21.96万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 21.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 21.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 21.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)